The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review

Am J Clin Dermatol. 2024 Nov;25(6):951-966. doi: 10.1007/s40257-024-00891-y. Epub 2024 Oct 5.

Abstract

Cannabidiol (CBD) is a non-psychotropic cannabinoid with multiple pharmacological properties. Cannabidiol has attracted growing attention in the cosmetic industry, with an increasing number of CBD-containing skincare products on the market in recent years. The aim of this review is to evaluate the current evidence on the use of CBD for cosmetic purposes. Following an overview of CBD and the endocannabinoid system in the skin, we summarize pre-clinical and clinical studies that address the potential of CBD in cosmetic dermatology. Available in vitro and in vivo evidence suggests that CBD has anti-oxidant, anti-inflammatory, moisturizing, anti-acne, wound-healing, and anti-aging properties. However, only a few clinical studies have been conducted on the use of CBD in the skin. In addition, there is a critical need to develop an efficient drug-delivery system for topical/transdermal application of CBD. Further research, including clinical and pharmacokinetic studies, are needed to fully evaluate the role of CBD in cosmetic dermatology.

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous*
  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology
  • Cannabidiol* / administration & dosage
  • Cannabidiol* / pharmacology
  • Cannabidiol* / therapeutic use
  • Cosmetics / administration & dosage
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / pharmacology
  • Dermatologic Agents / therapeutic use
  • Dermatology / methods
  • Humans
  • Skin / drug effects
  • Skin / metabolism
  • Skin Aging / drug effects
  • Wound Healing / drug effects

Substances

  • Cannabidiol
  • Dermatologic Agents
  • Antioxidants
  • Cosmetics
  • Anti-Inflammatory Agents